Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL AI Verdict: SKIP
Price: $82.99 Analyst target: $88.38 Upside: 6.49%
ZTS has collapsed from a 52-week high of $145.51 to $81.02, trading far below its SMA50 ($99.20) and SMA200 ($152.44). ADX of 69 confirms a violent downtrend, and the bounce to the upper Bollinger band ($81.48) and 3-month resistance ($80.59) with RSI 52 is a relief rally, not a clean oversold entry. The probable catalyst is rising competition (Morningstar cut its fair value but kept the wide moat), a structural pricing/share concern rather than a one-off panic, even though valuation looks cheap at 12x forward P/E with a 27.7% margin.
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.
See the full interactive analysis & chart →Informational only — not investment advice.